| STAT5A/B blockade sensitizes prostate cancer to radiation through inhibition of RAD51 and DNA repair C Maranto, V Udhane, DT Hoang, L Gu, V Alexeev, K Malas, K Cardenas, ... Clinical Cancer Research 24 (8), 1917-1931, 2018 | 51 | 2018 |
| Pro-invasive stimuli and the interacting protein Hsp70 favour the route of alpha-enolase to the cell surface G Perconti, C Maranto, DP Romancino, P Rubino, S Feo, A Bongiovanni, ... Scientific reports 7 (1), 3841, 2017 | 25 | 2017 |
| Cellular stress induces cap-independent alpha-enolase/MBP-1 translation C Maranto, G Perconti, F Contino, P Rubino, S Feo, A Giallongo FEBS letters 589 (16), 2110-2116, 2015 | 25 | 2015 |
| Enzalutamide-induced feed-forward signaling loop promotes therapy-resistant prostate cancer growth providing an exploitable molecular target for Jak2 inhibitors V Udhane, C Maranto, DT Hoang, L Gu, A Erickson, S Devi, PG Talati, ... Molecular cancer therapeutics 19 (1), 231-246, 2020 | 22 | 2020 |
| Second-generation Jak2 inhibitors for advanced prostate cancer: are we ready for clinical development? P Beinhoff, L Sabharwal, V Udhane, C Maranto, PS LaViolette, ... Cancers 13 (20), 5204, 2021 | 13 | 2021 |
| Cytokines, JAK-STAT signaling and radiation-induced DNA repair in solid tumors: Novel opportunities for radiation therapy WA Hall, L Sabharwal, V Udhane, C Maranto, MT Nevalainen The international journal of biochemistry & cell biology 127, 105827, 2020 | 9 | 2020 |
| Prospects for clinical development of Stat5 inhibitor IST5-002: high transcriptomic specificity in prostate cancer and low toxicity in vivo C Maranto, V Udhane, J Jia, R Verma, G Müller-Newen, PS LaViolette, ... Cancers 12 (11), 3412, 2020 | 6 | 2020 |
| Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis G Perconti, F Pratesi, F Angelotti, L Manca, I Puxeddu, P Rubino, ... Clin. Exp. Rheumatol 38, 115-119, 2020 | 4 | 2020 |
| The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line … V Udhane, C Maranto, D Hoang, A Erickson, S Devi, K Jacobsohn, ... Journal of Clinical Oncology 37 (7_suppl), 221-221, 2019 | 2 | 2019 |
| Stat5 mediates enzalutamide-resistant prostate cancer growth M Nevalainen, V Udhane, C Maranto, D Hoang, L Gu, A Erickson, S Devi, ... European Urology Supplements 18 (1), e1337, 2019 | 1 | 2019 |
| Abstract A014: ClpP drives efficacy and mediates acquired resistance with imipridones ONC201 and ONC206 in glioma in vitro C Maranto, S Foster, A Lee, P Sethna, JE Allen, VV Prabhu Cancer Research 84 (5_Supplement_1), A014-A014, 2024 | | 2024 |
| Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling C Maranto, L Sabharwal, V Udhane, SP Pitzen, B McCluskey, S Qi, ... Science Advances 10 (9), eadi2742, 2024 | | 2024 |
| Role of ClpP in the Anti-cancer Effects of Imipridone ONC201 and ONC206 A Lee, C Maranto, S Foster, S Morrow, JE Allen, R Lanier, P Sethna, ... Cancer Research 83 (7_Supplement), 4914-4914, 2023 | | 2023 |
| Role of ClpP and Mitochondrial Metabolism in the Anti-cancer Effects of Imipridone ONC201 and ONC206 in Glioblastoma and DIPG S Foster, A Lee, C Maranto, JE Allen, R Lanier, P Sethna, VV Prabhu Neuro-oncology 24, 234-234, 2022 | | 2022 |
| Abstract B073: Stat5a/b blockade sensitizes prostate cancer to radiation through inhibition of Rad51 and DNA repair C Maranto, V Udhane, A Dagvadorj, DT Hoang, L Gu, V Alexeev, K Malas, ... Cancer Research 78 (16_Supplement), B073-B073, 2018 | | 2018 |
| Role of Enolase/MBP-1 in non-tumorigenic and cancer cells C Maranto Università degli Studi di Palermo, 2015 | | 2015 |
| Cellular stress positively regulates the expression of Myc promoter-Binding Protein-1 (MBP-1). G Perconti, F Contino, C Maranto, P Rubino, S Feo, A Giallongo CSSA, 2012 | | 2012 |
